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Background: Conventional power studies possess limited ability to assess the performance of cluster detection
tests. In particular, they cannot evaluate the accuracy of the cluster location, which is essential in such
assessments. Furthermore, they usually estimate power for one or a few particular alternative hypotheses and
thus cannot assess performance over an entire region. Takahashi and Tango developed the concept of extended
power that indicates both the rate of null hypothesis rejection and the accuracy of the cluster location. We
propose a systematic assessment method, using here extended power, to produce a map showing the
performance of cluster detection tests over an entire region.
Methods: To explore the behavior of a cluster detection test on identical cluster types at any possible location,
we successively applied four different spatial and epidemiological parameters. These parameters determined
four cluster collections, each covering the entire study region. We simulated 1,000 datasets for each cluster
and analyzed them with Kulldorff’s spatial scan statistic. From the area under the extended power curve,
we constructed a map for each parameter set showing the performance of the test across the entire region.
Results: Consistent with previous studies, the performance of the spatial scan statistic increased with the
baseline incidence of disease, the size of the at-risk population and the strength of the cluster (i.e., the relative
risk). Performance was heterogeneous, however, even for very similar clusters (i.e., similar with respect to the
aforementioned factors), suggesting the influence of other factors.
Conclusions: The area under the extended power curve is a single measure of performance and, although
needing further exploration, it is suitable to conduct a systematic spatial evaluation of performance. The
performance map we propose enables epidemiologists to assess cluster detection tests across an entire
study region.
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Contexte: Les études de puissance ont montré leurs limites dans l’évaluation des performances des tests de
détection d’agrégats. En raison de la nécessité de prendre en compte à la fois la capacité du test à rejeter
l’hypothèse nulle et à localiser correctement l’agrégat, la puissance usuelle ne peut refléter la véritable performance
de ces tests. De plus, ces évaluations ne traitent en général qu’un nombre limité d’hypothèses alternatives ignorant
donc le comportement de ces tests sur l’ensemble d’une région d’étude. Takahashi et Tango ont proposé le
concept de puissance étendue qui, au-delà de la puissance usuelle, reflète également la précision de localisation de
l’agrégat. Nous proposons une méthode d’évaluation systématique, fondée ici sur la puissance étendue, pour
produire une carte offrant une visualisation synoptique des performances des tests de détection d’agrégats sur
l’ensemble d’une région.
Méthodes: De façon à explorer le comportement d’un test de détection d’agrégats sur un même type
d’agrégat pour toutes les localisations possibles, nous avons fixé quatre jeux de paramètres spatiaux et
épidémiologiques, de façon à simuler quatre collections d’agrégats, chacune couvrant l’ensemble de la région
d’étude. Mille jeux de données ont été simulés pour chaque agrégat et soumis au scan spatial de Kulldorff.
A partir de l’aire sous la courbe de puissance étendue, nous avons produit une carte de performance pour
chaque jeu de paramètres.
Résultats: Conformément aux précédentes études, la performance du scan spatial croît avec l’incidence de
base de la maladie, la taille de la population à risque et la force de l’agrégat (i.e., le risque relatif). Cependant,
même pour des agrégats très similaires, la performance du test est hétérogène, suggérant l’influence
potentielle d’autres facteurs.
Conclusions: L’aire sous la courbe de puissance étendue est une mesure unique de performance et, bien
qu’elle nécessite des évaluations plus poussées, elle convient à l’évaluation spatiale systématique de la
performance. La carte de performance que nous proposons autorise les épidémiologistes à évaluer les tests
de détection d’agrégats sur l’ensemble d’une région d’étude.Background
Spatial clusters can be detected using a wide range of
statistical tests [1,2], many of which are available in free
software packages such as R [3,4]. Epidemiologists use
local methods to detect clusters without a priori
knowledge of their location, and to determine their
significance. Because these cluster detection tests (CDTs)
must reveal both the presence and location of clusters,
performance studies have been constrained by the
limitations of conventional estimation techniques. For
example, a CDT may have maximum power for rejecting
the null hypothesis (cluster absence), yet be incapable of
accurately locating the simulated cluster. CDT performance
is also a function of epidemiological and geographical con-
text [1,5-11]. Furthermore, because epidemiological (e.g.,
incidence and relative risk) and geographical (e.g., spatial
unit size and shape) factors tend to be intrinsically
linked, their proper or common effects are difficult to
evaluate. When evaluating the behavior of these CDTs
in a particular region, limited knowledge can conse-
quently be gleaned by simulating one or a few clusters
in that region, and even less knowledge can be accrued
from studies on other region.
Takahashi and Tango have proposed the concept of
extended power (EP) [12,13] as a more accurate measureof CDT performance. This measure assesses both the
probability that the null hypothesis is rejected and the
accuracy of the cluster location. As such, it overcomes
the inadequacy of conventional power measures. How-
ever, EP cannot eliminate the need to define what is
meant by “an accurate” or “sufficiently accurate” loca-
tion. The level of spatial accuracy depends upon context;
for instance, an epidemiologist will require higher spatial
accuracy for an ad hoc study than for a survey system.
Takahashi and Tango therefore introduced a quantitative
indicator of spatial accuracy, and summarized CDT per-
formance using an EP curve in conjunction with this
spatial accuracy indicator.
In this work, we propose a method that integrates the
area under the EP curve (AUCEP) in order to produce
maps that provide a global overview of CDT perform-
ance over an entire study region.
Methods
Clustering model
To explore CDT behavior on same-class clusters in all
possible locations, we set common spatial and epidemio-
logical characteristics for four cluster collections cover-
ing the entire study region. The study region was the
Auvergne region (France), divided into n = 221 spatial
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collection of approximately circular clusters with four
SUs was identified within the study region. To achieve
this outcome, the 221 SUs were successively associated
with their three nearest neighbors as defined by
Euclidian distances between the SU centroids. To obtain
four cluster collections, we applied four combinations of
two baseline risks (incidences) and two relative risks to
the same at-risk population, whose size was estimated by
mean annual number of live births.
For a realistic analysis, we used data archived in CEMC
(birth defects registry for the Auvergne region) and INSEE
(National Institute of Statistics and Economic Studies) data-
bases. We collected two categories of data from 1999 to
2006: all birth defects and cardiovascular birth defects. Both
datasets were sorted by SU. The number of live births was
approximated by the number of birth declarations in the
at-risk population. Global annual incidences of all birth
defects (Iall) and cardiovascular birth defects (ICV) were
estimated as 2.26% and 0.48% of births, respectively. In the
analysis, we constructed risk combinations of these two
incidences at relative risks of 3 and 6.
Datasets
For each cluster within the four categories (221 × 4), we
generated 1,000 datasets, i.e., a total of 884,000 datasets.
Each dataset consisted of 221 rows and 5 columns. The
rows contained SU coordinates (longitude and latitude),
observed number of cases, size of the at-risk population
(i.e., the number of live births) and expected number of
cases in the specified SU. This last quantity was the
product of the global incidence (Iall or ICV) and the at-
risk population size in the SU. The observed case num-
bers were assumed as independent Poisson variables
such that
H0 : E Nið Þ ¼ εi;Ni ∼ Pois εið Þ; i ¼ 1;…; n
H1 : E Nið Þ ¼ πi;Ni ∼ Pois πið Þ;πi ¼ Iθεi þ εi 1−Ið Þ; i ¼ 1;…; n

where Ni is the observed number of cases, εi denote the
expected number of cases in the ith SU under the null
hypothesis of risk homogeneity (H0) and πi the expected
number of cases in the ith SU under the alternative hy-
pothesis of one simulated cluster (H1). θ is the relative
risk, and I is a binary indicator set to 1 if the ith SU is
within the simulated cluster, and 0 otherwise.
Measure of performance
The extended power was proposed by Takahashi and Tango
as an improved measure of CDT performance. For a par-
ticular cluster, global performance is the weighted cumula-
tive sum of the contribution of each detected cluster in all
submitted datasets. Here, we summarize the constructionof the performance indicator. For a more detailed descrip-
tion, the reader is referred to Takahashi and Tango [12,13].
Within a simulated cluster of s SUs, if the null hypoth-
esis is rejected, the size l of a detected cluster and its s*
SUs (where s* denotes a subset of s) are recorded. A
maximum cluster size L is imposed, such that if l > L,
the detected cluster is discarded. This limit prevents very
large, meaningless clusters from contributing to CDT
global performance. In this work, L was set to 30 SUs.
All eligible detected clusters (EDCs), i.e. with l ≤ L, are
counted and sorted by l and s*. For each combined value
of l and s*, the proportion of corresponding detected
clusters (P(l,s*)) in all submitted datasets is assigned a
weight W(l,s*). This weight is also a function of the
detection accuracy (i.e., the correct location of the
simulated cluster). Thus, Takahashi and Tango define
W(l,s*,w+,w−) as
W l;s;wþ;w−ð Þ ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1−min w− s−sð Þ; 1f g½  1−min wþ l−sð Þ; 1f g½ 
p
where w− and w+ are penalties for false negative and
false positive SUs, respectively. The penalties w− and w+
are determined according to the following constraints.
For w−, detected clusters that generate no false negative
must fully contribute to global performance, and those
that induce s false negatives must be discarded. These
constraints are satisfied when
w− ¼ 1=s
For w+, detected clusters that generate no false positive
must fully contribute to global performance, and those
that induce at least l0 false positives must be discarded.
These constraints are satisfied when
wþ ¼ 1=l0
So that l0 is not assigned arbitrarily, Takahashi and
Tango specify the ratio
q ¼ wþ=w−
To favor sensitivity over specificity (as is usually pre-
ferred), w− is greater than or equal to w+; thus l0 ≥ s
because 1/s ≥ 1/l0. For example, when:
 l0 ¼ s;w− ¼ wþ and q ¼ 1;
 l0 ¼ 2s;w− ¼ 2wþ and q ¼ 0:5;
 l0→∞;wþ ¼ 0 and q¼0:
For each value of q, the extended power is the cumula-
tive sum of W(l,s*,q) × P(l,s*), where l runs from 1 to L and
s* runs from 0 to s. CDT global performance in detecting
a particular cluster is then represented by the extended
power curve with q running from 0 to 1. At any point
 n  n−n
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between 0 and 1. Furthermore, we note that the ex-
tended power is a monotonically decreasing function of
q. Consequently, the area under the extended power




W l;s;qð Þ  P l;sð Þ
 
dq
is between 0 and 1, with 0 signifying an inoperative CDT
(s* always null) and 1 a perfect CDT (H0 always rejected,
with all detected clusters exactly overlaying the simu-
lated cluster). As suggested by Takahashi and Tango
[13], we used the area under the extended power curve
as the measure of CDT performance.
Performance mapping
Global performance was visualized over the entire region
using maps representing the measured AUCEP for each
collection of clusters.
The AUCEP is a measure of a cluster and thus associ-
ated with four SUs. In order to obtain a global overview
on a single map, we assigned the AUCEP value of each
cluster, to its central SU. Thus, we affected a single
measure of AUCEP to each SU of the map. As we
defined four cluster collections for four risks combin-
ation (incidence and relative risks), we produced four
performance maps.
Kulldorff’s Spatial scan statistic
In this study, we selected Kulldorff ’s spatial scan
statistic [14,15], a well-known and widely used CDT
whose performance has been studied by many authors
[1,6,10,16]. The spatial scan statistic detects the most
likely cluster based on locally observed statistics of
likelihood ratio tests. The scan statistic considers all
possible zones z defined by two parameters: a center
that is successively placed on the centroid of each SU,
and a radius varying between 0 and a predefined max-
imum. The true geography being delineated by admin-
istrative tracts, i.e., each zone z defined by all SUs
whose centroids lie within the circle, is irregularly
shaped. Let Nz and nz be the size of the at-risk
population and the number of cases counted in zone z
(over the entire region, these quantities are the total
population size N and the total number of cases n, re-
spectively). The probabilities that an at-risk case lies
inside or outside zone z are respectively defined by pz
= nz/Nz and qz = (n − nz)/(N −Nz). Given the null hy-
pothesis H0: pz = qz versus the alternative H1: pz > qz
and assuming a Poisson distribution of cases, Kulldorff





I nz > λNz½ 
where λ is global incidence, and the indicator function
I equals 1 when the number of observed cases in zone
z exceeds the expected number under H0, and 0 other-
wise. The circle yielding the highest likelihood ratio is
identified as the most likely cluster. The p-value is
obtained by Monte Carlo inference.
Software
Data simulation and analysis (see Data and Script in the
Additional files 1 and 2) were performed in R 2.14.0
[3,17-19] using AUVERGRID [20].
Results
The Auvergne region is characterized by low and
medium mountains situated around a central plain.
The at-risk population (see Methods) was heteroge-
neously distributed throughout sparsely populated areas
(mainly borderland and mountainous) and highly po-
pulated urban areas. Figure 1 shows the size of the
at-risk population in each cluster, which was assigned
to its central SU.
Figure 2 demonstrates how CDT performance im-
proved with increasing risk level. Clearly, the CDT
could not detect clusters within regions with low num-
ber of births. For these clusters, performance only mar-
ginally improved, even at the highest risk combination
(Figure 3).
CDT performance increased monotonically with the
at-risk population size (Figure 3). We noted a stronger
heterogeneity of CDT performance for the clusters with
the largest populations, especially at intermediate risk
levels (Figure 3); by this, we mean that clusters with
nearly the same population size led to slightly different
test performance behaviors. For example, Figure 4 shows
test performance in detecting three clusters centered on
SUs “43770” (red cluster in the figure), “03700” (blue
cluster) and “03420” (green cluster), which had popula-
tion sizes of 544, 558 and 545 births (mean number over
8 years), respectively. At the lowest risk level, the red
cluster was the only one even marginally detected,
whereas under other configurations, the blue cluster was
best detected. The worst detection performance was ex-
hibited with respect to the green cluster, particularly at
intermediate risk levels. We note that the green cluster
was the only borderland cluster.
Some summary statistics of the AUCEP distribu-
tions are displayed in Table 1. Figure 5 shows two
different extended power curves (and thus two dif-
ferent CDT behaviors) that have nearly equal AUCEP.
One of these clusters was centered on SU “03160”,
the other on SU “63112”.
Figure 1 Size of the at-risk population for each cluster in the Auvergne region, as defined by mean number of live births per year
between 1999 and 2006 (source: INSEE). Q1: ≤ 102; Q2: > 102 and≤ 175; Q3: > 175 and≤ 293; Q4: >293.
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datasets required about 5 days of computational time
using the AUVERGRID grid.
Discussion
Takahashi and Tango [13] have suggested using the
AUCEP to compare performance between CDTs. We
used this synthetic indicator, suitable for compiling
maps, to describe CDT performance. It thus fulfills our
primary goal of realizing a systematic performance as-
sessment of a CDT over an entire study area, rather than
over only a few clusters. This mapping method, although
using Takahashi and Tango’s extended power, is not
dependent on this concept. Our method can use any
other indicator that meets the requirements of being a
scalar (i.e., a single measure of performance) indicating
both the spatial accuracy of the detection and the
capacity of cluster detection tests to reject the null
hypothesis.Interpretation of the AUCEP requires further explor-
ation, however. Although a higher AUCEP clearly signi-
fies stronger CDT performance, quite different behaviors
can yield the same AUCEP. As shown in Figure 5, differ-
ent curves can possess very similar AUCEP values. This
figure shows the extended power curves “03160” and
“63112”, whose AUCEP values are nearly equal (0.931
and 0.932, respectively), but which reflect different CDT
behaviors. The procedures used to construct these
curves are described in detail within separate spread-
sheets (see EP curve in the Additional file 3).
The curve “63112” is nearly horizontal, indicating that
the EDCs (H0 rejected, and cluster size l <maximum
cluster size L) located the simulated cluster with high ac-
curacy. As q increases, less tolerance is given to false
positives until, eventually, only EDCs with at least one
true positive and less than s false positives can contrib-
ute to the extended power. A near zero slope thus
indicates that the same detected clusters, all of which
Figure 2 AUCEP of Kulldorff’s spatial scan. AUCEP was measured for four combinations of two relative risk (RR) and two annual incidence of
birth defects: low RR = 3 and high RR = 6; low incidence = 0.48% births and high incidence = 2.26% births.
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extended power, regardless of q.
The intercept of curve “63112” is 0.939, meaning that
eligible clusters (l < L), all of which contribute to the
extended power (i.e., all clusters contain at least one
true positive), were detected in 93.9% of the tests (H0
rejected).
To summarize curve “63112”, the simulated cluster
was not always detected (no H0 rejection or EDC with-
out true positive); however, provided that an EDC identi-
fied at least one true positive, the location was accurate
(i.e., less than s false positives existed in the cluster).
In contrast, the curve “03160” yields the same AUCEP,
but is negatively sloped with an intercept of 0.951. Thus,
the associated CDT produced more EDCs containing at
least one true positive. The negative slope indicates thata higher proportion of these EDCs generated at least s
false positives.
To summarize curve “03160”, the test rejected H0
more often and/or produced more EDCs, but located
the simulated cluster with less accuracy (i.e., this analysis
produced more than s false positives).
One particular curve has intercept equal to 1 (q = 0)
and a zero slope. An intercept equal to 1 implies that
the CDT always rejects H0 and that no false negatives
exist in the EDCs. All detected clusters entirely overlap
the simulated cluster, as in all other cases the weighting
function W(l, s*, q=0) is less than one. In addition, the zero
slope indicates the perfect test that always exactly locates
the simulated cluster. A perfect test always rejects H0,
and detected clusters always satisfy l = s* = s (i.e., gener-
ate no false positive or negative). The AUCEP of a perfect
Figure 3 AUCEP of Kulldorff’s spatial scan based on the size of the at-risk population for four combinations of two relative risk (RR)
and two annual incidence of birth defects: low RR = 3 and high RR = 6; low incidence = 0.48% births and high incidence = 2.26% births.
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than one.
The intercept of an extended power curve can be
regarded as a “quantitative” feature of CDT perform-
ance (all EDCs generating true positives contribute
to the extended power), whereas the slope may be
thought of as a “qualitative” feature of CDT perform-
ance, assessing location accuracy. The parameter q
can, in fact, be regarded as a continuous indicator
reflecting to what extent a detected cluster must accur-
ately locate the simulated cluster to contribute to the
performance measure.Figure 4 AUCEP of Kulldorff’s spatial scan and locations of three simu
two annual incidence of birth defects: low RR = 3 and high RR = 6; lowAs shown in Figure 5, however, if an entire curve is
condensed into a single measure (such as the AUC),
some information is lost, because CDTs with different
behaviors (i.e., curves with different shapes) can yield
the same performance value.
Consequently, the impact of CDT behavior on the ex-
tended power curve must be thoroughly explored, and
behaviors relevant to a particular research or application
need to be defined. Through such exploration, the extent
to which the AUCEP is a relevant performance measure,
and the purposes for which it is most suited, can be
determined.lated clusters for four combinations of two relative risk (RR) and
incidence = 0.48% births and high incidence = 2.26% births.
Table 1 AUCEP distribution for each risk combination and






Mean (SD) Min - Max
ICV and RR = 3 ≤ 102 0.010 (0.003) 0.003 - 0.020
[102, 175] 0.021 (0.006) 0.007 - 0.033
[175, 293] 0.043 (0.013) 0.023 - 0.077
> 293 0.133 (0.089) 0.055 - 0.542
Iall and RR = 3 ≤ 102 0.070 (0.028) 0.019 - 0.138
[102, 175] 0.183 (0.038) 0.119 - 0.268
[175, 293] 0.382 (0.075) 0.246 - 0.543
> 293 0.713 (0.117) 0.492 - 0.950
ICV and RR = 6 ≤ 102 0.061 (0.025) 0.016 - 0.110
[102, 175] 0.185 (0.047) 0.114 - 0.297
[175, 293] 0.412 (0.083) 0.277 - 0.553
> 293 0.768 (0.113) 0.524 - 0.971
Iall and RR = 6 ≤ 102 0.511 (0.162) 0.168 - 0.787
[102, 175] 0.874 (0.050) 0.783 - 0.959
[175, 293] 0.970 (0.019) 0.915 - 0.995
> 293 0.990 (0.010) 0.964 - 1
amean number between 1999 and 2006.
Figure 5 Extended power curves for two simulated clusters. Line 0316
Auvergne); line 63112: cluster centered on the SU with zip code 63112 (cen
and a baseline incidence of birth defects set to 2.26%.
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trarily set parameter. In this work, the parameter L, that
determines the maximum allowed size for EDCs, has
been set to 30 SUs. Takahashi and Tango [12] initially
proposed to set the limit L to one fourth or one third of
region size (in numbers of SUs). The authors stated that
it was not unreasonable to assume that an actual cluster
size will be less than such a limit. Such arguments are
often open to dispute but in any case, it is an arbitrary
decision. In our view, it would be more correct to set L
according to the size s of the simulated cluster because,
in the simulation, it is the “real” cluster. By construction,
the consequences of this arbitrary setting are limited to
the lowest values of q. Indeed, low values of q mean that
EDCs with false positives are less penalized, and thus
large clusters are allowed to contribute to EP. In our
case (L = 30), only values of extended power for q ≤ 0.15
could be underestimated, and only if we consider that
detected clusters more than 7.5 times larger than the
simulated cluster (4 SUs) are still meaningful. At last,
compared with L set to 30, computing AUCEP with L
equal to 221 (i.e. without an arbitrary limit) yields a dif-
ference in AUCEP always less than 10
-5 in this work.
In producing our performance map, we chose to as-
sign the AUCEP value of a single cluster of four SUs to a
single SU. Because two clusters centered on neighboring0: cluster centered on the SU with zip code 03160 (northwest
tral Auvergne). Both clusters were simulated with a relative risk of 6
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ates the detection of the entire cluster, visualizing
performance on a single map can only be done in two
ways. On the one hand, the AUCEP of a cluster can be
assigned to each of its SUs, or on the other hand, it can
be assigned to a single, albeit arbitrarily chosen, SU. In
the first solution, as each SU has a strong probability to
be associated with more than one cluster, it is then ne-
cessary to compute a summary statistic, such as the
mean, to produce a single map. In our view, it seems
more comprehensible to arbitrary assign the perform-
ance measure for the whole cluster on a single SU. As
we simulated more or less circular clusters, the central
SU of the cluster was naturally chosen for this assign-
ment. When simulating different cluster shapes, this
choice will clearly be less obvious. We nevertheless rec-
ommend assigning the performance measure to the SU
where the centroid of the cluster is located.
Authors who have studied CDT behavior mentioned
its dependence on epidemiological and geographical fac-
tors [1,5-11]. Consistent with previously published re-
sults, the performance of Kulldorff ’s spatial scan, and
more generally, all local CDTs, improves in study re-
gions of small SUs, large populations, high incidence of
the studied phenomenon and for clusters with strong
relative risk. Furthermore, as shown in Figure 4 and
Table 1, the variation in AUCEP among very similar sim-
ulated clusters (identical length, shape, population size
and risk association) suggests that other factors influ-
ence CDT performance. To our knowledge, no other
simulation study has been performed to both assess and
visualize CDT performance over an entire region. Until
now, authors have always considered a limited set of
simulated clusters with particular epidemiological or
geographical characteristics of interest. Consider the
typical example of population size effect. To assess this
effect, clusters are generally simulated in only a few arbi-
trarily chosen locations where a CDT behavior is as-
sumed to be representative of its behavior in any other
“similar” location. Usually, clusters in rural areas are
compared with clusters in urban areas. Such studies are
not sufficient to assess this factor that, as we have shown
(Figure 3), has a strong relationship with CDT perform-
ance. Furthermore, population size cannot explain in it-
self all the variability in CDT performance.
However, some authors [21] have assessed performance
on many randomly located clusters, which is a way to take
into account the effect of spatial location without assessing
it. It enabled them to assess the effect of factors such as
relative risk or spatial resolution without the potential con-
founding effect of the spatial location. Still, this approach,
while accounting for this effect, cannot quantify it.
Our systematic evaluation allows us to assess exactly
when heterogeneity is most important, and thus withinwhat population size range we can expect any other po-
tential factor to have a maximum effect. In this work, we
used predefined values for incidence and clustering
characteristics (relative risk, shape, size and number) to
generate performance maps. Epidemiologists should use
reasonable values if a priori knowledge is available for
some factors. However, the proper effect of any factor
on CDT performance can be studied with this systematic
evaluation, provided it uses suitable measure such as the
AUCEP.Conclusion
Given that CDT performance depends on geographical
and epidemiological context, the performance of these
methods should be explored prior to monitoring a par-
ticular phenomenon in a given region. This work enables
epidemiologists to study global CDT performance over
an entire region. Furthermore, from a research view-
point, our method seems beneficial for unraveling the
proper effect of many factors, particularly geographical
ones, on CDT performance.Additional files
Additional file 1: Script: This file is an r script (script.r) containing a
complete procedure to define the collection of clusters, simulate
the datasets, perform the test and plot the corresponding
performance map.
Additional file 2: Data: This is a zip file (Data.zip) containing the
population data in an r format (Pop.rda) and a folder with the
shapefiles for the Auvergne region.
Additional file 3: EP curve: This file is an Excel spreadsheet
(EP curve.xls) containing two worksheets. Sheets “03160” and “63112”
describe step-by-step construction of EP curves for clusters centered on
SU “03160” and SU “63112”, respectively. In both constructions, the
relative risk is set to 6 and the baseline incidence of birth defects is
assumed to be 2.26%. To toggle between the corresponding procedures
for calculating EP, the user need only alter the value of q in cell D41.Abbreviations
AUCEP: Area under the curve of extended power; CDT: Cluster detection test;
EDC: Eligible detected cluster; EP: Extended power; H0: Null hypothesis;
H1: Alternative hypothesis; Iall: Incidence of all birth defects; Icv: Incidence of
cardiovascular birth defects; RR: Relative risk.
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